| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962920 | Vaccine | 2015 | 10 Pages |
Abstract
These results support bridging the efficacy findings with 9vHPV vaccine in young women 16-26 years of age to men 16-26 years of age.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
X. Castellsagué, A.R. Giuliano, S. Goldstone, A. Guevara, O. Mogensen, J.M. Palefsky, T. Group, C. Shields, K. Liu, R. Maansson, A. Luxembourg, S.S. Kaplan,